Phase 3 study of first-line pembrolizumab ± vibostolimab (anti-TIGIT) in patients with PD-L1‒positive metastatic NSCLC Meeting Abstract
| Authors: | Hellmann, M. D.; Cho, B. C.; Juergens, R.; Cheng, Y.; De Castro, G. Jr; Erman, M.; Bauman, J. R.; Takahashi, T.; Schwarzenberger, P.; Zhang, P.; Pietanza, M. C.; Yang, J. C. |
| Abstract Title: | Phase 3 study of first-line pembrolizumab ± vibostolimab (anti-TIGIT) in patients with PD-L1‒positive metastatic NSCLC |
| Meeting Title: | 2021 World Conference on Lung Cancer |
| Keywords: | pembrolizumab; metastatic non-small-cell lung cancer; vibostolimab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2021 Sep 8-14 |
| Meeting Location: | Virtual event |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-10-01 |
| Start Page: | S1010 |
| End Page: | S1011 |
| Language: | English |
| ACCESSION: | WOS:000709606500331 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.08.331 |
| Notes: | Meeting Abstract: P14.01 -- Source: Wos |
